Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling (Q42114497)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 May 2015
edit
Language Label Description Also known as
English
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling
scientific article published on 12 May 2015

    Statements

    Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling (English)
    1 reference
    0 references
    0 references
    0 references
    0 references
    Barbara Rinaldi
    1 reference
    Loredana Sodano
    1 reference
    Giulia Gritti
    1 reference
    Eugenio Martuscelli
    1 reference
    Augusto Orlandi
    1 reference
    Francesco Rossi
    1 reference
    Maria Gabriella Matera
    1 reference
    12 May 2015
    1 reference
    172
    1 reference
    14
    1 reference
    3627-3637
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit